Liquidia (LQDA) Other Non Operating Income (2021 - 2024)
Liquidia's (LQDA) quarterly Other Non Operating Income came in at $7.2 million in Q3 2024, up 131.35% quarter-over-quarter from -$23.0 million in Q2 2024.
Liquidia (LQDA) Other Non Operating Income (2021 - 2024) Analysis & Trends
Liquidia's Other Non Operating Income history runs 4 years deep, the most recent figure standing at $7.2 million for Q3 2024.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to $7.2 million in Q3 2024; TTM through Dec 2024 was -$4.3 million, a 85.33% decrease from a year earlier, with the FY2024 full-year figure at -$4.3 million, down 84.68% from the prior year.
- Other Non Operating Income climbed to $7.2 million in Q3 2024 per LQDA's latest filing, from -$23.0 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $11.5 million in Q1 2024 and bottomed at -$23.0 million in Q2 2024.
- The 4-year median for Other Non Operating Income is -$50000.0 (2021), against an average of -$955500.0.
- Across the five-year window, Other Non Operating Income plunged 1781.13% in 2022 and surged 596.88% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at $47000.0 in 2021, then tumbled by 2221.28% to -$997000.0 in 2022, then slumped by 131.8% to -$2.3 million in 2023, then soared by 411.55% to $7.2 million in 2024.
- Per Business Quant, the three latest LQDA Other Non Operating Income figures stand at $7.2 million (Q3 2024), -$23.0 million (Q2 2024), and $11.5 million (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 7.20 Mn |
| Jun 30, 2024 | -22.97 Mn |
| Mar 31, 2024 | 11.48 Mn |
| Mar 31, 2023 | -2.31 Mn |
| Mar 31, 2022 | -997,000.00 |
| Dec 31, 2021 | 47,000.00 |
| Sep 30, 2021 | -47,000.00 |
| Mar 31, 2021 | -53,000.00 |